Daryan A Kaveh
Overview
Explore the profile of Daryan A Kaveh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khatri B, Keeble J, Dagg B, Kaveh D, Hogarth P, Ho M
Sci Rep
. 2021 Dec;
11(1):23308.
PMID: 34857776
Two strains of mice (BALB/c and CB6F1) were vaccinated with a range of Bacille Calmette-Guérin (BCG) Danish doses from 3 × 10 to 30 CFU/mouse, followed by aerosol infection with...
2.
Kaveh D, Garcia-Pelayo M, Bull N, Sanchez-Cordon P, Spiropoulos J, Hogarth P
Sci Rep
. 2020 Oct;
10(1):18703.
PMID: 33127956
Heterologous BCG prime-boost regimens represent a promising strategy for an urgently required improved tuberculosis vaccine. Identifying the mechanisms which underpin the enhanced protection induced by such strategies is one key...
3.
Bull N, Kaveh D, Garcia-Pelayo M, Stylianou E, McShane H, Hogarth P
Vaccine
. 2018 Aug;
36(37):5625-5635.
PMID: 30097220
Tuberculosis (TB) is the biggest cause of human mortality from an infectious disease. The only vaccine currently available, bacille Calmette-Guérin (BCG), demonstrates some protection against disseminated disease in childhood but...
4.
Edwards J, Everett H, Pedrera M, Mokhtar H, Marchi E, Soldevila F, et al.
Sci Rep
. 2017 Jan;
7:40942.
PMID: 28106145
Conventional dendritic cells (cDC) are professional antigen-presenting cells that induce immune activation or tolerance. Two functionally specialised populations, termed cDC1 and cDC2, have been described in humans, mice, ruminants and...
5.
Kaveh D, Garcia-Pelayo M, Webb P, Wooff E, Bachy V, Hogarth P
Vaccine
. 2016 Jun;
34(34):4003-11.
PMID: 27317453
Boosting BCG using heterologous prime-boost represents a promising strategy for improved tuberculosis (TB) vaccines, and adenovirus (Ad) delivery is established as an efficacious boosting vehicle. Although studies demonstrate that intranasal...
6.
Garcia-Pelayo M, Kaveh D, Sibly L, Webb P, Bull N, Cutting S, et al.
Tuberculosis (Edinb)
. 2016 May;
98:97-103.
PMID: 27156624
Tuberculosis (TB) remains a global pandemic, in both animals and man, and novel vaccines are urgently required. Heterologous prime-boost of BCG represents a promising strategy for improved TB vaccines, with...
7.
Blunt L, Hogarth P, Kaveh D, Webb P, Villarreal-Ramos B, Vordermeier H
Vaccine
. 2015 Nov;
33(51):7276-7282.
PMID: 26549366
Bovine tuberculosis (bTB) remains a globally significant veterinary health problem. Defining correlates of protection can accelerate the development of novel vaccines against TB. As the cultured IFNγ ELISPOT (cELISPOT) assay...
8.
Garcia-Pelayo M, Bachy V, Kaveh D, Hogarth P
Tuberculosis (Edinb)
. 2014 Dec;
95(1):48-53.
PMID: 25467292
It is generally assumed that the inbred mouse strains BALB/c (H-2(d)) and C57BL/6 (H-2(b)) respond to mycobacterial infection with distinct polarisation of T helper responses, with C57BL/6 predisposed to Th1...
9.
Kaveh D, Garcia-Pelayo M, Hogarth P
Vaccine
. 2014 Dec;
32(51):6911-6918.
PMID: 25444816
Tuberculosis (TB) remains one of the most important infectious diseases of man and animals, and the only available vaccine (BCG) requires urgent replacement or improvement. To facilitate this, the protective...
10.
Jones G, Khatri B, Garcia-Pelayo M, Kaveh D, Bachy V, Hogarth P, et al.
Clin Vaccine Immunol
. 2013 Aug;
20(11):1675-82.
PMID: 23986315
Previous experiments for the identification of novel diagnostic or vaccine candidates for bovine tuberculosis have followed a targeted approach, wherein specific groups of proteins suspected to contain likely candidates are...